An independent source of information on U.S. brand name drugs for health professionals

Drugdocs Logo

An independent source of information on U.S. brand name drugs for health professionals

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Pizensy

Chemical Namelactitol
Dosage FormSolution (oral; 10 g/packet, 280 g/bottle, 560 g/bottle)
Drug ClassMiscellaneous
SystemDigestive
CompanyBraintree Laboratories
Approval Year2020

Indication

  • Pizensy is indicated for chronic idiopathic constipation (cic) in adults.
Last updated on 10/19/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Pizensy (lactitol) Prescribing Information2020Sebela Pharmaceuticals
Document TitleYearSource
Efficacy and tolerance of lactitol supplementation for adult constipation: A systematic review and meta-analysis.2015Clinical and Experimental Gastroenterology